NORTHWEST BIOTHERAPEUTICS INC Debt Conversion, Original Debt, Amount
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Debt Conversion, Original Debt, Amount of $11.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2026-04-15
- NORTHWEST BIOTHERAPEUTICS INC debt conversion, original debt, amount for the quarter ending 2021-12-31 was $0.00.
- NORTHWEST BIOTHERAPEUTICS INC debt conversion, original debt, amount for the quarter ending 2021-09-30 was $0.00.
- NORTHWEST BIOTHERAPEUTICS INC debt conversion, original debt, amount for the quarter ending 2021-06-30 was $800.00K.
- NORTHWEST BIOTHERAPEUTICS INC debt conversion, original debt, amount for the quarter ending 2021-03-31 was $4.80M.
- NORTHWEST BIOTHERAPEUTICS INC debt conversion, original debt, amount for fiscal 2025 was $11.10M.
- NORTHWEST BIOTHERAPEUTICS INC debt conversion, original debt, amount for fiscal 2021 was $5.60M.
- NORTHWEST BIOTHERAPEUTICS INC debt conversion, original debt, amount for fiscal 2012 was $2.30M.
| Period end | Debt Conversion, Original Debt, Amount 1 month | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $11.10M 10-K · filed 2026-04-15 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $800.00K derived: sum of 3 quarters · filed 2023-02-28 | $5.60M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $800.00K derived: sum of 2 quarters · filed 2021-11-15 | $5.60M 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $5.60M 10-Q · filed 2021-08-16 | |||
| 2021-04-30 | $800.00K 10-Q · filed 2021-05-17 | ||||
| 2021-03-31 | $4.80M 10-Q · filed 2021-05-17 | ||||
| 2013-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.90M 10-Q · filed 2013-08-14 | $29.70M derived: sum of 3 quarters · filed 2013-08-14 | $32.90M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2013-03-31 | $900.00K 10-Q · filed 2013-05-15 | $28.70M derived: sum of 2 quarters · filed 2013-05-15 | $31.90M derived: sum of 3 quarters · filed 2013-05-15 | ||
| 2012-12-31 | $27.80M 10-K · filed 2013-04-08 | $31.00M derived: sum of 2 quarters · filed 2013-04-08 | $2.30M 10-K · filed 2013-04-08 | ||
| 2012-10-31 | $1.10M 10-Q · filed 2012-11-14 | ||||
| 2012-09-30 | $3.20M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $7.90M 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | $4.70M 10-Q/A · filed 2012-09-12 |